A new Yale-led study published Thursday identified a new target for treating the most common form of cancer in children and ...

The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...

At the recent American Society of Hematology annual meeting, researchers presented preclinical data examining how ...

Hematologist-oncologists are doctors who specialize in treating blood cancers such as acute lymphoblastic leukemia (ALL). ALL is a rare, rapidly progressing cancer of the blood and bone marrow. The ...

Acute lymphoblastic leukemia (ALL) is known as a pediatric leukemia, with approximately half of cases occurring in children. ALL is the most common childhood malignancy, representing 75% to 80% of ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational next-generation CD19-directed CAR-T cell therapy that is manufactured in 48 hours using ...

In patients with Ph-positive disease, TKIs should be used continuously, which may lead to toxicities. This must be considered during therapy selection. The optimal duration of TKI maintenance is not ...

Biphenotypic leukemia is a mixed type of leukemia that originates in both lymphoid and myeloid cells. It typically has a poorer outlook than other acute leukemias. A stem cell transplant may improve ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...